PHK
YMAB

Point72 Hong Kong’s Y-mAbs Therapeutics YMAB Stock Holding History

Point72 Hong Kong’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-995
Closed -$28K – 2465
2021
Q3 		$28K Buy
+995
New +$31.4K ﹤0.01% 1636
2021
Q1 		– Sell
-580
Closed -$29K – 2264
2020
Q4 		$29K Buy
+580
New +$26.8K ﹤0.01% 1348
2018
Q4 		– Sell
-3,252
Closed -$86K – 1249
2018
Q3 		$86K Buy
+3,252
New +$82.7K 0.03% 368

Other funds holding YMAB

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Point72 Hong Kong's YMAB Position: Q4 2021 in Review

Point72 Hong Kong sold out of Y-mAbs Therapeutics (YMAB) in Q4 2021, closing a stake of 995 shares — an estimated $28K sold.

Point72 Hong Kong first reported a position in YMAB in Q3 2018 and held it in 3 quarters. The position peaked at $86K in Q3 2018. 97 funds tracked by Wall St. Rank hold YMAB as of Q4 2021.

  • Point72 Hong Kong reported no remaining Y-mAbs Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Point72 Hong Kong sold 995 Y-mAbs Therapeutics shares in Q4 2021, an estimated $28K.
  • Point72 Hong Kong first reported a position in Y-mAbs Therapeutics in Q3 2018 and held it in 3 quarters.
  • Point72 Hong Kong's Y-mAbs Therapeutics position peaked at $86K in Q3 2018.
  • 97 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q4 2021.

Based on Point72 Hong Kong's 13F filing for Q4 2021, filed 14 Feb 2022.